Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 47% ± 22% | |
| classical monocyte | 18 studies | 27% ± 10% | |
| non-classical monocyte | 15 studies | 23% ± 9% | |
| monocyte | 7 studies | 22% ± 5% | |
| deuterosomal cell | 4 studies | 27% ± 7% | |
| macrophage | 4 studies | 20% ± 4% | |
| myeloid cell | 3 studies | 19% ± 2% | |
| epithelial cell | 3 studies | 23% ± 1% | |
| alveolar macrophage | 3 studies | 22% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 2076.23 | 180 / 180 | 100% | 28.55 | 430 / 430 |
| thymus | 100% | 5461.50 | 653 / 653 | 100% | 33.09 | 605 / 605 |
| uterus | 100% | 2137.97 | 170 / 170 | 99% | 29.40 | 455 / 459 |
| prostate | 100% | 2201.12 | 245 / 245 | 98% | 14.89 | 493 / 502 |
| bladder | 100% | 1298.19 | 21 / 21 | 97% | 18.34 | 487 / 504 |
| brain | 98% | 1931.61 | 2598 / 2642 | 98% | 21.20 | 691 / 705 |
| breast | 100% | 1914.33 | 459 / 459 | 96% | 20.12 | 1071 / 1118 |
| pancreas | 97% | 1028.17 | 317 / 328 | 99% | 21.09 | 176 / 178 |
| intestine | 100% | 1376.84 | 965 / 966 | 94% | 13.02 | 497 / 527 |
| adrenal gland | 100% | 1505.15 | 258 / 258 | 94% | 11.42 | 216 / 230 |
| skin | 96% | 907.19 | 1740 / 1809 | 98% | 17.23 | 461 / 472 |
| lung | 100% | 3588.49 | 578 / 578 | 94% | 15.23 | 1080 / 1155 |
| kidney | 100% | 2570.44 | 89 / 89 | 92% | 24.28 | 828 / 901 |
| stomach | 96% | 1054.65 | 345 / 359 | 92% | 11.09 | 264 / 286 |
| esophagus | 97% | 1179.65 | 1405 / 1445 | 89% | 9.68 | 162 / 183 |
| liver | 84% | 685.58 | 190 / 226 | 71% | 8.76 | 290 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 33.58 | 29 / 29 |
| spleen | 100% | 4953.47 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 28.28 | 1 / 1 |
| adipose | 100% | 1741.34 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 3301.51 | 924 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 23.47 | 44 / 45 |
| eye | 0% | 0 | 0 / 0 | 98% | 14.62 | 78 / 80 |
| heart | 88% | 805.23 | 757 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 83% | 812.90 | 1103 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 30% | 175.61 | 237 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005829 | Cellular component | cytosol |
| GO_0005515 | Molecular function | protein binding |
| GO_0043130 | Molecular function | ubiquitin binding |
| Gene name | UBXN11 |
| Protein name | UBX domain-containing protein 11 (Colorectal tumor-associated antigen COA-1) (Socius) (UBX domain-containing protein 5) UBX domain protein 11 |
| Synonyms | UBXD5 SOC PP2243 |
| Description | FUNCTION: May be involved in the reorganization of actin cytoskeleton mediated by RND1, RND2 and RND3. Promotes RHOA activation mediated by GNA12 and GNA13 (By similarity). . |
| Accessions | Q5T124 Q5T118 ENST00000442942.6 ENST00000374217.7 [Q5T124-2] X6RIY5 ENST00000421827.2 X6RDK7 ENST00000357089.8 [Q5T124-2] ENST00000452980.5 X6R8K8 ENST00000374222.6 [Q5T124-1] ENST00000374221.7 [Q5T124-1] ENST00000314675.11 [Q5T124-3] X6R8M6 ENST00000374223.5 ENST00000450041.6 Q5T130 ENST00000374215.5 X6RDY0 ENST00000423664.5 |
